Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease

John Koreth, Haesook T. Kim, Kyle T. Jones, Paulina B. Lange, Carol G. Reynolds, Marie J. Chammas, Katherine Dusenbury, Jennifer Whangbo, Sarah Nikiforow, Edwin P. Alyea, Philippe Armand, Corey S. Cutler, Vincent T. Ho, Yi Bin Chen, David Avigan, Bruce R. Blazar, Joseph H. Antin, Jerome Ritz, Robert J. Soiffer